About Rimonabant
Class: | Cannabinoid receptor antagonist
Use: | Adjunctive treatment for obesity management in adults with a BMI ≥30 kg/m² or ≥27 kg/m² with associated risk factors
Adult dose: | 20 mg once daily, taken orally
Pediatric dose: | Not approved for pediatric use
Side effects: | Nausea, vomiting, diarrhea, anxiety, depression, insomnia, headache, dizziness
Contraindications: | Hypersensitivity to rimonabant or any component of the formulation; severe hepatic impairment; pregnancy and lactat
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.